The ability to modify/visualize biological surfaces, and then study the modified cell/virion in a range of in vitro and in vivo environments is essential to gaining further insight into the function of specific molecules or the entire entity. Studies of biological surface modification are generally limited to genetic engineering of the organism or the covalent attachment of chemical moieties to the cell surface 1, 2 . However these traditional techniques expose the cell to chemical reactants, or they require significant manipulation to achieve the desired outcome, making them cumbersome, and they may also inadvertently affect the viability/functionality of the modified cell. A simple method to harmlessly modify the surface of cells is required.
. FSL constructs have been used in modifying embryos, spermatozoa, zebrafish, epithelial/endometrial cells, red blood cells, and virions to create quality controls systems and diagnostic panels, to modify cell adhesion/ interaction/ separation/ immobilization, and for in vitro and in vivo imaging of cells/virions [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] .
The process of modifying cells/virions is generic and extremely simple. The most common procedure is incubation of cells (in lipid free media) with a solution for FSL constructs for 1-2 hours at 37°C [4] [5] [6] [7] [8] [9] [10] . During the incubation the FSL constructs spontaneously incorporate into the membrane, and the process is complete. Washing is optional. Cells modified by FSL constructs are known as kodecytes [6] [7] [8] [9] , while virions are kodevirions 10 . FSL constructs as direct infusions and kodecytes/kodevirions have been used in experimental animal models 7, 8, 10 . All kodecytes/kodevirions appear to retain their normal vitality and functionality while gaining the new function of the F moiety 7, 8, 10, 11 . The combination of dispersibility in biocompatible media, spontaneous incorporation into cell membranes, and apparent low toxicity, makes FSL constructs valuable research tools for the study of cells and virions.
Video Link
The video component of this article can be found at https://www.jove.com/video/3289/
Protocol
The following protocol describes the generic procedure for the insertion of FSL constructs ( Figure 1 ) into biological membranes. For simplicity the protocol will only refer to cells (kodecytes), which are at a 100% concentration. However, the term cells is interchangeable with virions (kodevirions) or organisms or cellular structures and their concentration in diluent is not important, provided it is always consistent between tests, controls, and experiments. With red blood cells the packed cell volume is typically 80%, but with virions, embryos and other cells it is typically less than 1%. The method is very robust and will produce modified membranes when used by any of its variations, but refinement will be required to optimize and standardize the degree of modification required for specific applications.
Preparation of FSL Constructs
1. To prepare the FSL construct stock solution first reconstitute the dry FSL product (Table 1 ) by the addition of 1.0mL of diluent (or as specified in the product insert) to the product vial. Briefly sonicate (30 seconds). This will prepare a 1mg/mL solution, which can be aliquoted into 100 μL sterile containers and stored at 2-8°C for up to one week, or frozen for up to 3 months.
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Notes:
1. FSL constructs will usually insert into cells in lipid containing media but will typically require as much as a 50X higher FSL working concentrations than if in PBS or other lipid free media. 2. The working range dilutions will depend on the application, the detection method sensitivity, the type of FSL construct, and the degree of modification required. Typically the range of dilution will be between 10-500 μg of FSL per mL of diluent for carbohydrate FSL constructs and 1-100 μg/mL for other FSL constructs such as fluorophores and biotin. 3. If preparing insertion diluents containing multiple FSL construct, simply add the constructs together in the same diluent at their normal working concentration. If one construct is at much higher concentration than another, some adjustment (increase) in concentration may be required for the lesser construct. Alternatively constructs may be added sequentially, preferably with the highest concentration construct first, followed by the lesser. 4. FSL construct concentrations above 1000 μg/mL may introduce significant amounts of lipid into a cell membrane, and may change the shape of the cell or make it more susceptible to lysis. 5. FSL construct working solutions should be stored at 2-8°C and used within a few days. 6. FSL constructs can be diluted in water but will have reduced stability and must be used within hours. If the package insert specifies water as the reconstitution diluent the product in the vial will also contain salts (as specified in the package insert).
Insertion of FSL Construct(s) into Membranes
1. First wash the cells for FSL modification free of unbound lipids by centrifugation and using PBS or lipid free cell media as wash solution.
2. Pack the cells or suspend in 100 μL of diluent. 3. Simultaneously prepare controls which ideally should be both unmodified cells (incubated with PBS rather than FSL solution) and/or cells modified with a benign but related FSL construct. 4. Add 100 μL of an appropriate dilution of FSL solution (containing 1 or more FSL constructs) to the cells and incubate for 1-2 hours at 37°C. A similar result can be obtained by 6 hours incubation at 25°C or overnight (18 hours) at 4°C -mixing is recommended every few hours if heavy cell suspensions are used. 5. Wash (optional) twice with PBS or media to remove any free FSL constructs and prepare an appropriate suspension.
Notes:
1. The diluent used to suspend the cells can be cell culture media, PBS, cell storage solutions, etc, but preferably without lipids ( e.g. fetal calf serum) or detergents (e.g. TWEEN). 2. Different volumes (than 100 μL) ratios (than 1:1 cells/FSL solution) or incubation conditions of time and temperature may be used provided the same ratio, concentration, and volume are used to obtain reproducible results.
Handling and Visualization
1. Once the FSL modification process has been completed the kodecytes can be stored at 4-8°C in lipid free media or used. 2. Kodecytes and kodevirions generally behave the same as unmodified cells/virions and can be handled and viewed under normal testing systems (microscopy, serology, flow cytometry, etc). They usually have no special requirements except for the avoidance of solvents/ detergents/lipids that may elute the lipid constructs from membranes.
Notes:
1. Constructs will remain in the membrane of inactive cells, such as red cells, if stored in lipid free media for the life of the cell. In cells with active membranes the constructs will be internalized and metabolized, at a rate dependent on cell membrane activity. 2. Dead cells will usually contain high levels of FSL constructs; this can be used to separate nonviable cells from viable cells. 3. If kodecytes are stored (or used in vivo) in lipid containing media/environments, such as serum/plasma the construct will slowly elute from the membrane over a period of hours or days, depending on temperature and lipid concentrations/compositions.
Representative Results:
1. The following representative results depend on the construct used (Table 1) , its inserted concentration and the relative sensitivity and specificity of the detection system(s). In general all FSL constructs will insert into cells after 1 hour but the optimal conditions will need to be established for each situation. 2. FSL constructs can be used to label the outside of a variety of live cells [3] [4] [5] [6] [7] [8] [9] 11, 14 .
In the examples shown in Figure 2 embryos at different stages were used (as they are a fragile cell), but other cells ( Figure 3 3. Blood group markers of human or animal specificity can be attached to cells, including red cells [4] [5] [6] [7] [8] [9] (Figure 6 ). As the amount of FSL construct on a kodecyte is controllable and reproducible [4] [5] [6] , kodecytes for antibody quantitation can be made ( Table 2 and Figure 6 ). The actual source of cells is not important, they can be any species, or even of the same origin as the source of antibody, thereby ensuring on the only incompatible antigen is that introduced by the FSL 7, 8 (Figure 6 ). 
Discussion
Modifying cells and virions with FSL constructs is a very simple and robust technique [3] [4] [5] [6] [7] [8] [9] [10] [11] . To describe and distinguish FSL construct modified cells and virions from unmodified cells, they are termed kodecytes and kodevirions respectively [6] [7] [8] [9] [10] , but only when the introduced functional group can be shown to be present on their membrane. When kodecytes are made with different concentrations of FSL constructs, they can be referred to by the concentration of the FSL construct solution used to create them, e.g. 15 μg/mL A kodecytes, or if more than one FSL is used then a combined term, e.g. A+biotin kodecytes 7, 8 . When different cells are to be compared, including the cell type in the description is recommended, e.g. red cell biotin kodecytes or endometrial biotin kodecytes 7, 8 .
Although the process of insertion is very robust and insertion (albeit with different rates) will occur over a large temperature range from 4 -37°C and within minutes to hours, to obtain reproducible insertion strict control of contact time, temperature, FSL concentration (including diluent formulation), and to a lesser extent cell concentration are required. To date, all FSL constructs can be used to modify cells by the same technique [4] [5] [6] [7] [8] [9] [10] [11] , however it is expected that certain conditions will be more favorable to work-flow and/or the optimal handling requirements of the cells/virions to be modified. The exact FSL concentration to achieve the desired effect needs to be determined by the user 4 . The resultant FSL construct modified cells/virions can usually be used in the same manner as an unmodified cell/virion in biological or analytical systems [4] [5] [6] [7] [8] [9] [10] [11] . As the FSL constructs will slowly elute from modified surfaces when in contact with lipid solutions 7, 8 , or be consumed by active cells 11 , these issues must be considered with respect to the level of signal or activity obtained over periods of time. Kodecytes can be fixed (e.g. glutaraldehyde/ formalin) after insertion provided the fixative does not contain lipid-eluting solvents and the functional group is compatible with the fixative. Alternatively fixed cells can be modified with FSL constructs.
In addition to the modification of cell and virion surfaces FSL constructs can also be infused directly into the circulation of laboratory animals causing in vivo modification of circulating cells 7 and to inhibit viruses 12 , toxins, 12 and antibodies 7 . FLS constructs have also been used to decorate liposomes and can be printed onto paper surfaces 13 , where they immobilize, and can then be used in diagnostic assays.
The ability to easily modify live cells with an increasing range of FSL constructs should prove to be a useful research and development tool for the study of cell surface biology.
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